Global and China Oncology Companion Diagnostic Market Size, Status and Forecast 2024-2031

Report ID: 1025214 | Published Date: Sep 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Companion Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Polymerase Chain Reaction (PCR)
        1.2.3 Next-Generation Sequencing (NGS)
        1.2.4 Immunohistochemistry (IHC)
        1.2.5 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Oncology Companion Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Pathology/Diagnostic Laboratory
        1.3.4 Academic Medical Center
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oncology Companion Diagnostic Market Perspective (2016-2027)
    2.2 Oncology Companion Diagnostic Growth Trends by Regions
        2.2.1 Oncology Companion Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oncology Companion Diagnostic Historic Market Share by Regions (2016-2021)
        2.2.3 Oncology Companion Diagnostic Forecasted Market Size by Regions (2022-2027)
    2.3 Oncology Companion Diagnostic Industry Dynamic
        2.3.1 Oncology Companion Diagnostic Market Trends
        2.3.2 Oncology Companion Diagnostic Market Drivers
        2.3.3 Oncology Companion Diagnostic Market Challenges
        2.3.4 Oncology Companion Diagnostic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oncology Companion Diagnostic Players by Revenue
        3.1.1 Global Top Oncology Companion Diagnostic Players by Revenue (2016-2021)
        3.1.2 Global Oncology Companion Diagnostic Revenue Market Share by Players (2016-2021)
    3.2 Global Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oncology Companion Diagnostic Revenue
    3.4 Global Oncology Companion Diagnostic Market Concentration Ratio
        3.4.1 Global Oncology Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Companion Diagnostic Revenue in 2020
    3.5 Oncology Companion Diagnostic Key Players Head office and Area Served
    3.6 Key Players Oncology Companion Diagnostic Product Solution and Service
    3.7 Date of Enter into Oncology Companion Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Companion Diagnostic Breakdown Data by Type
    4.1 Global Oncology Companion Diagnostic Historic Market Size by Type (2016-2021)
    4.2 Global Oncology Companion Diagnostic Forecasted Market Size by Type (2022-2027)

5 Oncology Companion Diagnostic Breakdown Data by Application
    5.1 Global Oncology Companion Diagnostic Historic Market Size by Application (2016-2021)
    5.2 Global Oncology Companion Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Oncology Companion Diagnostic Market Size (2016-2027)
    6.2 North America Oncology Companion Diagnostic Market Size by Type
        6.2.1 North America Oncology Companion Diagnostic Market Size by Type (2016-2021)
        6.2.2 North America Oncology Companion Diagnostic Market Size by Type (2022-2027)
        6.2.3 North America Oncology Companion Diagnostic Market Size by Type (2016-2027)
    6.3 North America Oncology Companion Diagnostic Market Size by Application
        6.3.1 North America Oncology Companion Diagnostic Market Size by Application (2016-2021)
        6.3.2 North America Oncology Companion Diagnostic Market Size by Application (2022-2027)
        6.3.3 North America Oncology Companion Diagnostic Market Size by Application (2016-2027)
    6.4 North America Oncology Companion Diagnostic Market Size by Country
        6.4.1 North America Oncology Companion Diagnostic Market Size by Country (2016-2021)
        6.4.2 North America Oncology Companion Diagnostic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oncology Companion Diagnostic Market Size (2016-2027)
    7.2 Europe Oncology Companion Diagnostic Market Size by Type
        7.2.1 Europe Oncology Companion Diagnostic Market Size by Type (2016-2021)
        7.2.2 Europe Oncology Companion Diagnostic Market Size by Type (2022-2027)
        7.2.3 Europe Oncology Companion Diagnostic Market Size by Type (2016-2027)
    7.3 Europe Oncology Companion Diagnostic Market Size by Application
        7.3.1 Europe Oncology Companion Diagnostic Market Size by Application (2016-2021)
        7.3.2 Europe Oncology Companion Diagnostic Market Size by Application (2022-2027)
        7.3.3 Europe Oncology Companion Diagnostic Market Size by Application (2016-2027)
    7.4 Europe Oncology Companion Diagnostic Market Size by Country
        7.4.1 Europe Oncology Companion Diagnostic Market Size by Country (2016-2021)
        7.4.2 Europe Oncology Companion Diagnostic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oncology Companion Diagnostic Market Size (2016-2027)
    8.2 Asia-Pacific Oncology Companion Diagnostic Market Size by Type
        8.2.1 Asia-Pacific Oncology Companion Diagnostic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oncology Companion Diagnostic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oncology Companion Diagnostic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oncology Companion Diagnostic Market Size by Application
        8.3.1 Asia-Pacific Oncology Companion Diagnostic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Oncology Companion Diagnostic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Oncology Companion Diagnostic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Oncology Companion Diagnostic Market Size by Region
        8.4.1 Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oncology Companion Diagnostic Market Size (2016-2027)
    9.2 Latin America Oncology Companion Diagnostic Market Size by Type
        9.2.1 Latin America Oncology Companion Diagnostic Market Size by Type (2016-2021)
        9.2.2 Latin America Oncology Companion Diagnostic Market Size by Type (2022-2027)
        9.2.3 Latin America Oncology Companion Diagnostic Market Size by Type (2016-2027)
    9.3 Latin America Oncology Companion Diagnostic Market Size by Application
        9.3.1 Latin America Oncology Companion Diagnostic Market Size by Application (2016-2021)
        9.3.2 Latin America Oncology Companion Diagnostic Market Size by Application (2022-2027)
        9.3.3 Latin America Oncology Companion Diagnostic Market Size by Application (2016-2027)
    9.4 Latin America Oncology Companion Diagnostic Market Size by Country
        9.4.1 Latin America Oncology Companion Diagnostic Market Size by Country (2016-2021)
        9.4.2 Latin America Oncology Companion Diagnostic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oncology Companion Diagnostic Market Size (2016-2027)
    10.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Type
        10.2.1 Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Application
        10.3.1 Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Oncology Companion Diagnostic Market Size by Country
        10.4.1 Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Agilent Technologies, Inc.
        11.1.1 Agilent Technologies, Inc. Company Details
        11.1.2 Agilent Technologies, Inc. Business Overview
        11.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Introduction
        11.1.4 Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.1.5 Agilent Technologies, Inc. Recent Development
    11.2 Illumina, Inc.
        11.2.1 Illumina, Inc. Company Details
        11.2.2 Illumina, Inc. Business Overview
        11.2.3 Illumina, Inc. Oncology Companion Diagnostic Introduction
        11.2.4 Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.2.5 Illumina, Inc. Recent Development
    11.3 Qiagen N.V.
        11.3.1 Qiagen N.V. Company Details
        11.3.2 Qiagen N.V. Business Overview
        11.3.3 Qiagen N.V. Oncology Companion Diagnostic Introduction
        11.3.4 Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.3.5 Qiagen N.V. Recent Development
    11.4 Thermo Fisher Scientific Inc.
        11.4.1 Thermo Fisher Scientific Inc. Company Details
        11.4.2 Thermo Fisher Scientific Inc. Business Overview
        11.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Introduction
        11.4.4 Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.4.5 Thermo Fisher Scientific Inc. Recent Development
    11.5 F. Hoffmann-La Roche Ltd.
        11.5.1 F. Hoffmann-La Roche Ltd. Company Details
        11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
        11.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Introduction
        11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
    11.6 ARUP Laboratories
        11.6.1 ARUP Laboratories Company Details
        11.6.2 ARUP Laboratories Business Overview
        11.6.3 ARUP Laboratories Oncology Companion Diagnostic Introduction
        11.6.4 ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.6.5 ARUP Laboratories Recent Development
    11.7 Abbott
        11.7.1 Abbott Company Details
        11.7.2 Abbott Business Overview
        11.7.3 Abbott Oncology Companion Diagnostic Introduction
        11.7.4 Abbott Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.7.5 Abbott Recent Development
    11.8 Myriad Genetics, Inc.
        11.8.1 Myriad Genetics, Inc. Company Details
        11.8.2 Myriad Genetics, Inc. Business Overview
        11.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Introduction
        11.8.4 Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.8.5 Myriad Genetics, Inc. Recent Development
    11.9 bioMérieux SA
        11.9.1 bioMérieux SA Company Details
        11.9.2 bioMérieux SA Business Overview
        11.9.3 bioMérieux SA Oncology Companion Diagnostic Introduction
        11.9.4 bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.9.5 bioMérieux SA Recent Development
    11.10 Invivoscribe, Inc.
        11.10.1 Invivoscribe, Inc. Company Details
        11.10.2 Invivoscribe, Inc. Business Overview
        11.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Introduction
        11.10.4 Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021)
        11.10.5 Invivoscribe, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Oncology Companion Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Polymerase Chain Reaction (PCR)
    Table 3. Key Players of Next-Generation Sequencing (NGS)
    Table 4. Key Players of Immunohistochemistry (IHC)
    Table 5. Key Players of In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
    Table 6. Key Players of Others
    Table 7. Global Oncology Companion Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Oncology Companion Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Oncology Companion Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Oncology Companion Diagnostic Market Share by Regions (2016-2021)
    Table 11. Global Oncology Companion Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Oncology Companion Diagnostic Market Share by Regions (2022-2027)
    Table 13. Oncology Companion Diagnostic Market Trends
    Table 14. Oncology Companion Diagnostic Market Drivers
    Table 15. Oncology Companion Diagnostic Market Challenges
    Table 16. Oncology Companion Diagnostic Market Restraints
    Table 17. Global Oncology Companion Diagnostic Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Oncology Companion Diagnostic Market Share by Players (2016-2021)
    Table 19. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Companion Diagnostic as of 2020)
    Table 20. Ranking of Global Top Oncology Companion Diagnostic Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Oncology Companion Diagnostic Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oncology Companion Diagnostic Product Solution and Service
    Table 24. Date of Enter into Oncology Companion Diagnostic Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Oncology Companion Diagnostic Revenue Market Share by Type (2016-2021)
    Table 28. Global Oncology Companion Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Oncology Companion Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Oncology Companion Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Oncology Companion Diagnostic Revenue Market Share by Application (2016-2021)
    Table 32. Global Oncology Companion Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Oncology Companion Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Oncology Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Oncology Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Oncology Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Oncology Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Oncology Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Oncology Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Oncology Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Oncology Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Oncology Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Oncology Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Oncology Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Oncology Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Oncology Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Oncology Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Agilent Technologies, Inc. Company Details
    Table 65. Agilent Technologies, Inc. Business Overview
    Table 66. Agilent Technologies, Inc. Oncology Companion Diagnostic Product
    Table 67. Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 68. Agilent Technologies, Inc. Recent Development
    Table 69. Illumina, Inc. Company Details
    Table 70. Illumina, Inc. Business Overview
    Table 71. Illumina, Inc. Oncology Companion Diagnostic Product
    Table 72. Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 73. Illumina, Inc. Recent Development
    Table 74. Qiagen N.V. Company Details
    Table 75. Qiagen N.V. Business Overview
    Table 76. Qiagen N.V. Oncology Companion Diagnostic Product
    Table 77. Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 78. Qiagen N.V. Recent Development
    Table 79. Thermo Fisher Scientific Inc. Company Details
    Table 80. Thermo Fisher Scientific Inc. Business Overview
    Table 81. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product
    Table 82. Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 83. Thermo Fisher Scientific Inc. Recent Development
    Table 84. F. Hoffmann-La Roche Ltd. Company Details
    Table 85. F. Hoffmann-La Roche Ltd. Business Overview
    Table 86. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product
    Table 87. F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 88. F. Hoffmann-La Roche Ltd. Recent Development
    Table 89. ARUP Laboratories Company Details
    Table 90. ARUP Laboratories Business Overview
    Table 91. ARUP Laboratories Oncology Companion Diagnostic Product
    Table 92. ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 93. ARUP Laboratories Recent Development
    Table 94. Abbott Company Details
    Table 95. Abbott Business Overview
    Table 96. Abbott Oncology Companion Diagnostic Product
    Table 97. Abbott Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 98. Abbott Recent Development
    Table 99. Myriad Genetics, Inc. Company Details
    Table 100. Myriad Genetics, Inc. Business Overview
    Table 101. Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 102. Myriad Genetics, Inc. Recent Development
    Table 103. bioMérieux SA Company Details
    Table 104. bioMérieux SA Business Overview
    Table 105. bioMérieux SA Oncology Companion Diagnostic Product
    Table 106. bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 107. bioMérieux SA Recent Development
    Table 108. Invivoscribe, Inc. Company Details
    Table 109. Invivoscribe, Inc. Business Overview
    Table 110. Invivoscribe, Inc. Oncology Companion Diagnostic Product
    Table 111. Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 112. Invivoscribe, Inc. Recent Development
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Companion Diagnostic Market Share by Type: 2020 VS 2027
    Figure 2. Polymerase Chain Reaction (PCR) Features
    Figure 3. Next-Generation Sequencing (NGS) Features
    Figure 4. Immunohistochemistry (IHC) Features
    Figure 5. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) Features
    Figure 6. Others Features
    Figure 7. Global Oncology Companion Diagnostic Market Share by Application: 2020 VS 2027
    Figure 8. Hospital Case Studies
    Figure 9. Pathology/Diagnostic Laboratory Case Studies
    Figure 10. Academic Medical Center Case Studies
    Figure 11. Oncology Companion Diagnostic Report Years Considered
    Figure 12. Global Oncology Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Oncology Companion Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Oncology Companion Diagnostic Market Share by Regions: 2020 VS 2027
    Figure 15. Global Oncology Companion Diagnostic Market Share by Regions (2022-2027)
    Figure 16. Global Oncology Companion Diagnostic Market Share by Players in 2020
    Figure 17. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Companion Diagnostic as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Oncology Companion Diagnostic Revenue in 2020
    Figure 19. Global Oncology Companion Diagnostic Revenue Market Share by Type (2016-2021)
    Figure 20. Global Oncology Companion Diagnostic Revenue Market Share by Type (2022-2027)
    Figure 21. North America Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Oncology Companion Diagnostic Market Share by Type (2016-2027)
    Figure 23. North America Oncology Companion Diagnostic Market Share by Application (2016-2027)
    Figure 24. North America Oncology Companion Diagnostic Market Share by Country (2016-2027)
    Figure 25. United States Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Oncology Companion Diagnostic Market Share by Type (2016-2027)
    Figure 29. Europe Oncology Companion Diagnostic Market Share by Application (2016-2027)
    Figure 30. Europe Oncology Companion Diagnostic Market Share by Country (2016-2027)
    Figure 31. Germany Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Oncology Companion Diagnostic Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Oncology Companion Diagnostic Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Oncology Companion Diagnostic Market Share by Region (2016-2027)
    Figure 41. China Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Oncology Companion Diagnostic Market Share by Type (2016-2027)
    Figure 49. Latin America Oncology Companion Diagnostic Market Share by Application (2016-2027)
    Figure 50. Latin America Oncology Companion Diagnostic Market Share by Country (2016-2027)
    Figure 51. Mexico Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Oncology Companion Diagnostic Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Oncology Companion Diagnostic Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Oncology Companion Diagnostic Market Share by Country (2016-2027)
    Figure 57. Turkey Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Oncology Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 61. Illumina, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 62. Qiagen N.V. Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 63. Thermo Fisher Scientific Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 65. ARUP Laboratories Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 66. Abbott Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 67. Myriad Genetics, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 68. bioMérieux SA Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 69. Invivoscribe, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technologies, Inc.
Illumina, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Invivoscribe, Inc.
Frequently Asked Questions
Oncology Companion Diagnostic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Companion Diagnostic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Companion Diagnostic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports